NIH Concerned About Serious Side Effects from Covid Vaccine 

I have said from the beginning that my husband and I will not get a Covid-19 Vaccine. First of all, we do not get flu shots. Secondly, this fast-tracked potential killer is a global accident waiting to happen.

Did I say accident?

From webmd.com

NIH Concerned About COVID Vaccine Side Effects

By Arthur Allen and Liz Szabo, Kaiser Health News

Monday, September 14, 2020 (Kaiser News) — The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched an investigation of the case.

“The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, an NIH division. “Everyone’s hopes are on a vaccine, and if you have a major complication, the whole thing could get derailed.”

A great deal of uncertainty remains about what happened to the unnamed patient, to the frustration of those avidly following the progress of vaccine testing. AstraZeneca, which is running the global trial of the vaccine it produced with Oxford University, said the trial volunteer recovered from a severe inflammation of the spinal cord and is no longer hospitalized.

AstraZeneca has not confirmed that the patient was afflicted with transverse myelitis, but Nath and another neurologist said they understood this to be the case. Transverse myelitis produces a set of symptoms involving inflammation along the spinal cord that can cause pain, muscle weakness and paralysis. Britain’s regulatory body, the Medicines and Healthcare Products Regulatory Agency, reviewed the case and has allowed the trial to resume in the United Kingdom.

AstraZeneca “need[s] to be more forthcoming with a potential complication of a vaccine which will eventually be given to millions of people,” said Nath. “We would like to see how we can help, but the lack of information makes it difficult to do so.”

Any decision about whether to continue the trial is complex because it’s difficult to assess the cause of a rare injury that occurs during a vaccine trial — and because scientists and authorities have to weigh the risk of uncommon side effects against a vaccine that might curb the pandemic.

“So many factors go into these decisions,” Nath said. “I’m sure everything is on the table. The last thing you want to do is hurt healthy people.”

The NIH has yet to get tissue or blood samples from the British patient, and its investigation is “in the planning stages,” Nath said. U.S. scientists could look at samples from other vaccinated patients to see whether any of the antibodies they generated in response to the coronavirus also attack brain or spinal cord tissue.

Such studies might take a month or two, he said. The FDA declined to comment on how long it would take before it decides whether to move forward.

Dr. Jesse Goodman, a Georgetown University professor and physician who was chief scientist and lead vaccine regulator at the FDA during the Obama administration, said the agency will review the data and possibly consult with British regulators before allowing resumption of the U.S. study, which had just begun when the injury was reported. Two other coronavirus vaccines are also in late-stage trials in the U.S.

If it determines the injury in the British trial was caused by the vaccine, the FDA could pause the trial. If it allows it to resume, regulators and scientists surely will be on the watch for similar symptoms in other trial participants.

A volunteer in an earlier phase of the AstraZeneca trial experienced a similar side effect, but investigators discovered she had multiple sclerosis that was unrelated to the vaccination, according to Dr. Elliot Frohman, director of the Multiple Sclerosis & Neuroimmunology Center at the University of Texas.

Neurologists who study illnesses like transverse myelitis say they are rare — occurring at a rate of perhaps 1 in 250,000 people — and strike most often as a result of the body’s immune response to a virus. Less frequently, such episodes have also been linked to vaccines.

The precise cause of the disease is key to the decision by authorities whether to resume the trial. Sometimes an underlying medical condition is “unmasked” by a person’s immune response to the vaccine, leading to illness, as happened with the MS patient. In that case, the trial might be continued without fear, because the illness was not specific to the vaccine.

More worrisome is a phenomenon called “molecular mimicry.” In such cases, some small piece of the vaccine may be similar to tissue in the brain or spinal cord, resulting in an immune attack on that tissue in response to a vaccine component. Should that be the case, another occurrence of transverse myelitis would be likely if the trial resumed, said Dr. William Schaffner, an infectious disease specialist at the Vanderbilt University School of Medicine. A second case would shut down the trial, he said.

In 1976, a massive swine flu vaccination program was halted when doctors began diagnosing a similar disorder, Guillain-Barré syndrome, in people who received the vaccine. At the time no one knew how common GBS was, so it was difficult to tell whether the episodes were related to the vaccine.

Eventually, scientists found that the vaccine increased the risk of the disorder by an additional one case among every 100,000 vaccinated patients. Typical seasonal flu vaccination raises the risk of GBS in about one additional case in every 1 million people.

“It’s very, very hard” to determine if one rare event was caused by a vaccine, Schaffner said. “How do you attribute an increased risk for something that occurs in one in a million people?”

Before allowing U.S. trials to restart, the FDA will want to see why the company and an independent data and safety monitoring board (DSMB) in the U.K. felt it was safe to continue, Goodman said. The AstraZeneca trial in the United States has a separate safety board.

FDA officials will need to review full details of the case and may request more information about the affected study volunteer before deciding whether to allow the U.S. trial to continue, Goodman said. They may also require AstraZeneca to update the safety information it provides to study participants.

It’s possible that the volunteer’s health problem was a coincidence unrelated to the vaccine, said Dr. Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security. Studies aren’t usually stopped over a single health problem, even if it’s serious.

Yet many health leaders have expressed frustration that AstraZeneca hasn’t released more information about the health problem that led it to halt its U.K. trial.

“There is just so little information about this that it’s impossible to understand what the diagnosis was or why the DSMB and sponsor were reassured” that it was safe to continue, Goodman said.

AstraZeneca has said it’s unable to provide more information about the health problem, saying this would violate patient privacy, although it didn’t say how.

But there’s an exceptional need for transparency in a political climate rife with vaccine hesitancy and mistrust of the Trump administration’s handling of the COVID-19 response, leading scientists say.

“While I respect the critical need for patient confidentiality, I think it would be really helpful to know what their assessment of these issues was,” Goodman said. “What was the diagnosis? If there wasn’t a clear diagnosis, what is it that led them to feel the trial could be restarted? There is so much interest and potential concern about a COVID-19 vaccine that the more information that can be provided, the more reassuring that would be.”

The FDA will need to balance any possible risks from an experimental vaccine with the danger posed by COVID-19, which has killed nearly 200,000 Americans.

“There are also potential consequences if you stop a study,” Goodman said.

If the AstraZeneca vaccine fails, the U.S. government is supporting six other COVID vaccines in the hope at least one will succeed. The potential problems with the AstraZeneca vaccine show this to be a wise investment, Adalja said.

“This is part of the idea of not having just one vaccine candidate going forward,” he said. “It gives you a little more insurance.

Schaffner said researchers need to remember that vaccine research is unpredictable.

“The investigators have inadvisedly been hyping their own vaccine,” Schaffner said. “The Oxford investigators were out there this summer saying, ‘We’re going to get there first.’ But this is exactly the sort of reason … Dr. [Anthony] Fauci and the rest of us have been saying, ‘You never know what will happen once you get into large-scale human trials.’” WebMD News from Kaiser Health News©2013-2020 Henry J. Kaiser Family Foundation. All rights reserved. source

I have to wonder why these medical “Experts” do not pour their resources into therapeutics instead of vaccines. Perhaps the CEO’s of the Big Pharma companies involved have their eyes on the prize – the VACCINE – because that’s where the BIG BUCKS are.

And also, we must not forget that lowering the population is a must for Bill Gates, et al.

Why do you think this PLANNEDdemic occurred in the first place?

How Can I be Saved?

Shalom b’Yeshua

MARANATHA!!

grandmageri422@gmail.com

Articles at grandmageri422.me

 

Since I wrote the original article, warning the body of Christ to NOT give donations to IFCJ led by Rabbi Eckstein, he passed away, and now his daughter (Yael Eckstein) is running the ministry.

As I clearly stated in the original article, Rabbi Eckstein (and family) are not Messianic Jews. The Rabbi was vehemently against Jews such as myself. After writing the article in 2015, many of the brethren wrote to me that they were very disappointed that they had been under the impression that IFJC was a Messianic outfit, and had given so much money to them for years.

The Rabbi’s annual income was well over $1 Million a year – much more than other leaders of ministries for the Jewish people. Also, the other ministries are Messianic, so the people of Israel are getting the Gospel and food supplies from the Messianic ministries.

We should pray for Yael to be saved, but as of right now, she follows in her father’s footsteps and loathes Jews who believe in Yeshua. She is also taking the exorbitant salary as did her father.

I have decided to republish the original article from 2015. Please remember that Rabbi Eckstein passed away in February of 2019, and the organization is now being run by his daughter, Yael.

Original Article

We have all seen the commercials from Rabbi Eckstein of IFCJ (International Fellowship of Christians and Jews) asking for your money to support his cause. He shows Jews in Israel [and countries such as Russia] – so hungry, that they are fighting each other to get the boxes of food. He says “Jews are so poor, they cannot even afford to buy matzo for Passover.”

Well, I have a few things to say about the good Rabbi – did I say good? Maybe you won’t think so after reading about this man and his organization.

Years ago, I began getting emails and mail from IFCJ. At first I thought that this was wonderful. But I wanted to vet this man to make sure he was on the up and up.

I knew many believers who gave religiously (pun intended) to Rabbi Eckstein. They seemed to think this man could do no wrong, and wanted to be a partner in supporting the Jewish people.

I started reading about him. He was not a believer in Yeshua. As a matter of fact, he is an Orthodox Rabbi. I actually wrote to him several times, and told him of my belief in Yeshua. I told him that he could not be saved without the forgiveness and belief in Yeshua. I never received a reply.

A few years ago, I saw Rabbi Eckstein on a Christian TV station. He was singing Jewish songs and talking about Judaism. It seemed to me that his purpose in doing this was perhaps to get his followers to become Jews. Now, with the Hebrew Roots cult abounding everywhere, I wonder how many of these folks were influenced by the Rabbi.

Before Moishe Rosen of Jews for Jesus went home to be with Yeshua, he wrote in “Moishe’s Musings” an article in which he spoke of Rabbi Eckstein. Here is an excerpt from his article:

From Moishe’s Musings of Jews for Jesus

“There is another kind of “lifestyle evangelism” that I can’t endorse. It’s the kind where people congratulate one another that actions speak louder than words, and that if others know they are a Christian, they need not say anything about Jesus so long as they live exemplary lives.

Isn’t it interesting that Rabbi Yechiel Eckstein, an Orthodox Jew, promoted this kind of evangelism in his article “Witnessing vs. Proselytizing,” which was posted online at the Christianity Today website. Eckstein concludes,

“If Christians want to share their faith with Jews, they should start by being good friends and neighbors, and wherever possible, ‘good Samaritans.’ Evangelicals call this style of witnessing ‘lifestyle evangelism,’ and it seems to me a self-evidently superior form of outreach.”

[Before you take that ringing endorsement of how to witness to Jewish people, you need to know that] Eckstein is a man of great sensitivity and tact, but he is not a believer, and his goal is not to see other Jews become believers. Helping people win Jews to Christ would make Eckstein anathema in the Jewish community. Yet some Christians regard him as an expert on how to successfully share their faith. Eckstein claims to uphold the Christian mandate to witness, but eventually he discloses his opinion that it is arrogant for Christians to think that Jewish people need Jesus.

I think that Christians should be concerned that Rabbi Eckstein has gained quite a platform among evangelical Christians. As reasonable and affirming of the Christian religion as Eckstein might seem, his commitment as an Orthodox rabbi is still at odds with those of us committed to seeing all people, including Jewish people, find salvation in Jesus.

I’m afraid that some Christians have been so flattered by Eckstein’s approach that the utter lack of logic in using him as an authority on Jewish evangelism escapes them. In a way, I am glad that Eckstein speaks so highly of “lifestyle evangelism” because it affords thinking Christians the opportunity to reflect on how to fulfill the Great Commission. The kind of lifestyle evangelism Eckstein praises centers on how nice people can be, whereas the Bible centers on why the cross is so necessary. And then there is the matter of his income. Oy vey – WHAT an income!

I found this information on many credible sites, but this from Charisma Magazine articulated the facts so well:

As the head of a nonprofit that is almost entirely supported by donations, what makes Yechiel Eckstein’s compensation noteworthy is its proportion to his organization’s overall income compared to other ministries. While the salary and benefit package of the head of the International Fellowship of Christians and Jews (ICFJ) is at least five times higher than any other leader of an Israel-related ministry, clocking in at $1.2 million, Eckstein’s compensation is more than double what the president of World Vision—a ministry with a budget 10 times larger—earns.

World Vision’s Richard Stearns earned $456,718 in salary and benefits in 2011, according to the organization’s tax return. But World Vision has a $1 billion annual budget, whereas last year IFCJ’s budget was $113 million.

Meanwhile, Billy Graham, founder of the Billy Graham Evangelistic Association (BGEA), earned $228,448 in total compensation in 2011, and his son, Franklin Graham, president of BGEA, earned $115,307. The organization is similar in size to the IFCJ with $92 million in revenues in 2011.

Linda Lampkin, resource director for the Economic Research Institute office in Washington, D.C., calculated the average direct compensation for executive directors at similar-sized religious organizations and found Eckstein’s pay is well above the average, which is $276,807. The computer-generated comparison showed executive directors at organizations with similar-sized budgets—$100-$110 million—earned anywhere from $163,675 to $389,938 annually.

“It is fair to say an executive director at a religious organization who makes nearly $500,000 annually in direct compensation and also has significant other compensation is paid well outside the mean ranges of executive directors at similar organizations with an approximate $100 million to $110 million in revenues,” Lampkin told Charisma.

How much are those in charge of these Israel-related ministries actually making?

It’s often implied that any leader of a nonprofit ministry or organization who earns more than Mother Teresa is somehow gouging the public. Obviously, that isn’t true. Running a large organization—whether a college, a hospital or a church—is complicated and requires hard work. By not paying market-rate salaries, the talent needed to run such organizations tends to go to where he or she can be compensated commensurate with his or her ability. Even Jesus said a “laborer is worthy of his wages” (Luke 10:7).

Some organizations don’t like to reveal what their leaders make, however, because they fear donations would decrease if people knew. In the world of Christian ministries, that’s especially true—as proven by such examples as the short-lived “scandal” surrounding Franklin Graham’s compensation package as the head of both Samaritan’s Purse and the Billy Graham Evangelistic Association.

At the same time, in American culture there is a feeling that some financial matters should be out in the open. For example, it’s required by law that the public knows the salaries of elected officials. And those who run a publicly owned company must publicize the salaries of top management so investors can make investing decisions based on whether they feel those leaders are looking out for the investor or themselves.

Even the Bible says people do things differently in the light than in darkness. So in that spirit, Charisma inquired about the salaries of some of the ministries’ leaders.

We found ministry leaders’ pay ranged from zero to that of Eckstein. By comparison, leaders from three of the other largest Israel-related ministries earned substantially less: Jonathan Bernis earned $224,233 in total compensation (salary and benefits), Jews for Jesus Executive Director David Brickner earned $200,000, and Chosen People Ministries President Mitch Glaser earned $174,767. (The salary and benefit package of Christians United for Israel Executive Director David Brog could not be obtained.)

Among the other ministries, no salary was above $90,500. And with Eckstein’s removed from the equation, the average salary of those leaders willing to disclose their compensation—and including those who take no salary—was $85,856.

How We Came Up with This Report

Given the magnitude and importance of the mission of Israel-related ministries—and in an effort to help promote financial transparency, integrity in fundraising efforts and the proper use of donations—Charisma requested financial information from 17 Israel-related ministries.

To begin its seven-month investigation into the financial stewardship of these ministries, Charisma requested financial information from each organization, along with an interview with its president or lead representative. We also obtained the 990 tax returns that some of the ministries voluntarily filed with GuideStar, which tracks the finances of more than 1.8 million IRS-recognized nonprofits. Under federal law, ministries are not required to publicly disclose tax returns, but some do so voluntarily to be financially transparent.

In its examination of ministry finances, Charisma also consulted with the Evangelical Council for Financial Accountability (ECFA), which accredits various ministries, and Charity Navigator, an independent nonprofit organization that evaluates American charities. Of the 17 ministries, the following seven are accredited by ECFA: Chosen People Ministries, Jews for Jesus, Christian Friends of Israel, Bridges for Peace, Maoz Israel, Jewish Voice Ministries International, and the Messianic Jewish Israel Fund.

Having worked with many of the ministries in the past and seen their fruit up close through the years, Charisma’s intent was not to dig up any figurative buried skeletons, but instead to inform our readers as to the unique vision, purpose and scope of ministry for each organization. We believe financial stewardship goes hand in hand with this and, as a result, celebrate those Israel-related ministries that are taking every precaution to be faithful with what God has given them. – Source

Over $1 million a year?? That is absolutely sinful and wrong on so many levels. There is a word for a person like this in Yiddish – Goniff. It means a thief. I’m sorry to have to use this term, but what else can I call him?

If you give to International Fellowship of Christians and Jews, you may want to find another organization to which to donate your money. The Charisma magazine mentions some very good ones.

Do your homework! We have the Internet, and you can vet a person or organization very easily.

Personally, hubby and I give to Chosen People Ministries. It’s a wonderful, transparent organization.

Please continue giving to the Jewish people. Some very good ministries help Jews in Europe to make Aliyah.

Thank you for caring!

How Can I Be Saved?

Shalom b’Yeshua

MARANATHA!

grandmageri422@gmail.com